Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Intralipid: the new magic bullet in cardioprotection?

Literature DB >> 23612140

Intralipid: the new magic bullet in cardioprotection?

Matthias L Riess, Mihai V Podgoreanu.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23612140 PMCID： PMC3918444 DOI： 10.1097/ALN.0b013e31828bac35

Source DB: PubMed Journal: Anesthesiology ISSN： 0003-3022 Impact factor: 7.892

× No keyword cloud information.

11 in total

1. Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

Authors: Parisa Partownavid; Soban Umar; Jingyuan Li; Siamak Rahman; Mansoureh Eghbali
Journal: Crit Care Med Date: 2012-08 Impact factor: 7.598

2. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.

Authors: Jingyuan Li; Andrea Iorga; Salil Sharma; Ji-Youn Youn; Rod Partow-Navid; Soban Umar; Hua Cai; Siamak Rahman; Mansoureh Eghbali
Journal: Anesthesiology Date: 2012-10 Impact factor: 7.892

3. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.

Authors: Soban Umar; Rangarajan D Nadadur; Jingyuan Li; Federica Maltese; Parisa Partownavid; Arnoud van der Laarse; Mansoureh Eghbali
Journal: Hypertension Date: 2011-07-11 Impact factor: 10.190

4. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.

Authors: Jianhua Feng; Eliana Lucchinetti; Preeti Ahuja; Thomas Pasch; Jean-Claude Perriard; Michael Zaugg
Journal: Anesthesiology Date: 2005-11 Impact factor: 7.892

1. Intralipid postconditioning in patients of cardiac surgery undergoing cardiopulmonary bypass (iCPB): study protocol for a randomized controlled trial.

Authors: Yuan Yuan; Hui Xiong; Yan Zhang; Hong Yu; Rong-Hua Zhou
Journal: Trials Date: 2020-11-23 Impact factor: 2.279

1 in total

Intralipid: the new magic bullet in cardioprotection?

1. Fatty-acid oxidation and calcium homeostasis are involved in the rescue of bupivacaine-induced cardiotoxicity by lipid emulsion in rats.

2. Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.

3. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats.

4. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.

5. Characterization of fatty acid clearance in premature neonates during intralipid infusion.

6. Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.

7. Comparative studies on a new concentrated fat emulsion: Intralipid 30% vs. 20%.

8. Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity.

9. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo.

Review 10. Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent.

1. Intralipid postconditioning in patients of cardiac surgery undergoing cardiopulmonary bypass (iCPB): study protocol for a randomized controlled trial.